The Lautenberg Center for Immunology and Cancer Research, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Sci Adv. 2024 May 31;10(22):eadn7732. doi: 10.1126/sciadv.adn7732. Epub 2024 May 29.
Structural maintenance of chromosomes flexible hinge domain-containing 1 (SMCHD1) is a noncanonical SMC protein and an epigenetic regulator. Mutations in SMCHD1 cause facioscapulohumeral muscular dystrophy (FSHD), by overexpressing DUX4 in muscle cells. Here, we demonstrate that SMCHD1 is a key regulator of alternative splicing in various cell types. We show how SMCHD1 loss causes splicing alterations of DNMT3B, which can lead to hypomethylation and DUX4 overexpression. Analyzing RNA sequencing data from muscle biopsies of patients with FSHD and Smchd1 knocked out cells, we found mis-splicing of hundreds of genes upon SMCHD1 loss. We conducted a high-throughput screen of splicing factors, revealing the involvement of the splicing factor RBM5 in the mis-splicing of DNMT3B. Subsequent RNA immunoprecipitation experiments confirmed that SMCHD1 is required for RBM5 recruitment. Last, we show that mis-splicing of DNMT3B leads to hypomethylation of the D4Z4 region and to DUX4 overexpression. These results suggest that DNMT3B mis-splicing due to SMCHD1 loss plays a major role in FSHD pathogenesis.
染色质结构维持因子 1 (SMCHD1)是一种非典型的 SMC 蛋白和表观遗传调节剂。SMCHD1 中的突变会导致面肩肱型肌营养不良症(FSHD),因为它在肌肉细胞中过表达了 DUX4。在这里,我们证明了 SMCHD1 是各种细胞类型中可变剪接的关键调节因子。我们展示了 SMCHD1 缺失如何导致 DNMT3B 的剪接改变,从而导致低甲基化和 DUX4 的过表达。分析 FSHD 患者的肌肉活检和 Smchd1 敲除细胞的 RNA 测序数据,我们发现 SMCHD1 缺失后数百个基因的剪接发生错误。我们进行了剪接因子的高通量筛选,揭示了剪接因子 RBM5 参与了 DNMT3B 的剪接错误。随后的 RNA 免疫沉淀实验证实,SMCHD1 是 RBM5 募集所必需的。最后,我们证明了 DNMT3B 的剪接错误导致了 D4Z4 区域的低甲基化和 DUX4 的过表达。这些结果表明,由于 SMCHD1 缺失导致的 DNMT3B 剪接错误在 FSHD 的发病机制中起主要作用。